PRE Prenetics Global Ltd NASDAQ · United States

Prenetics Global (PRE) news

Prenetics Global Ltd is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PRE, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Prenetics Global news

We have not published a story on Prenetics Global yet. When there is news, it will appear here.

Prenetics Global annual financials

Line	FY2024	FY2023
Revenue		$21.7 million
Research and development	$10.9 million	$11.7 million
Net income (loss)	-$49.8 million	-$64.8 million
Cash from operations	-$28.9 million	-$13.8 million
Cash and equivalents	$52.3 million	$45.7 million

Latest balance sheet, Dec 31, 2024 (20-F): cash and equivalents $52.3 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Prenetics Global

What is the ticker symbol of Prenetics Global?

Prenetics Global Ltd trades under the ticker PRE on NASDAQ.

Where is Prenetics Global listed?

Prenetics Global Ltd is listed on NASDAQ.

Which country or territory is Prenetics Global listed under?

Our directory records Prenetics Global Ltd under United States.

Does aibio.space cover Prenetics Global?

aibio.space lists Prenetics Global Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

Is Prenetics Global profitable?

Prenetics Global Ltd reported a net loss of $49.8 million for the fiscal year ended Dec 31, 2024, and used $28.9 million of cash in operations, per its annual report to the SEC.

How much does Prenetics Global spend on research and development?

$10.9 million in the fiscal year ended Dec 31, 2024, per its annual report.

How much cash does Prenetics Global have?

$52.3 million in cash at Dec 31, 2024, per its 20-F.

Investor discussion: Prenetics Global

Members talk about Prenetics Global (PRE). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Prenetics Global, newest first. Each line links the filing it comes from.

May 4, 2026Financings
Reported a financing. SEC Form 6-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:PRE on TradingView.

Listing details

Company: Prenetics Global Ltd
Ticker: PRE
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction